Urolithin A appears to be well-tolerated in healthy adults based on the clinical trials published so far, with no serious adverse events reported at commonly studied doses.[1][2] That said, the long-term safety picture is still developing, meaningful gaps remain for specific populations, and not every user has a positive experience.
What the research says
The most frequently cited safety data comes from trials conducted with Mitopure, a purified urolithin A ingredient developed by Amazentis. Phase 1 and Phase 2 trials published between 2019 and 2022 tested single and multiple doses in middle-aged and older adults, with 500 mg and 1,000 mg daily the doses carried into later trials [1][4]. Across those studies, urolithin A was generally well-tolerated, with no significant changes in kidney function parameters or liver enzymes after 28 days of 1,000 mg in one 50-person trial; a systematic review found no effect on cardiovascular outcomes either way [5][2].[1] The 2022 randomized trial published in JAMA Network Open (Liu et al.) missed both primary endpoints (6-minute walk distance and maximal muscle ATP production) in 66 adults aged 65 to 90; muscle endurance improved on a secondary endpoint. The trial was funded by Amazentis [3].[3] A separate 2022 trial in middle-aged adults, published in Cell Reports Medicine, did not meet its primary endpoint of peak power output; hamstring peak torque rose 12% from baseline in one dose group while the placebo group fell 9.8%. The trial was funded by Amazentis [4].[4] The earlier first-in-human safety study, often confused with these, was Andreux et al. in Nature Metabolism in 2019.[1]
Common side effects reported in trials: Mild gastrointestinal symptoms, including loose stools, nausea, and stomach discomfort, were the most frequently noted issues, with no clear dose pattern: in the middle-aged trial, 102 adverse events were reported by 45 participants (42 on placebo, 24 at 500 mg, 36 at 1,000 mg), and the authors judged urolithin A safe and well tolerated at both doses [4].
Who the research has not adequately studied:
- Pregnant and breastfeeding women. No safety trials exist for these populations, though in a small pilot of 10 breast-feeding mothers drinking pomegranate juice daily, urolithin A-glucuronide reached breast milk and the infants’ urine. Avoidance is the standard recommendation [6].
- Children and adolescents. All trials have been conducted in adults.
- People with active cancer. Urolithin A modulates autophagy and immune pathways. Whether this interacts with oncology treatments in a helpful or harmful way is genuinely unclear. Anyone in active cancer treatment should discuss this with their oncologist before using it.
- People on immunosuppressant drugs. Laboratory research, including a study highlighted in r/NicotinamideRiboside examining urolithin A’s effects on human microglial cells, suggests it differentially regulates innate immune responses. For people on drugs that are already modulating immunity, the interaction potential is unknown, and a 4-week randomized trial in 50 adults reported only very small shifts in T-cell measures (0.50 percentage points versus placebo) with nine adverse events in total, so the practical interaction risk is unknown [5].[5]
Drug interactions: No formally established drug interactions have been identified in clinical trials to date, but this does not mean none exist. Urolithin A’s effects on mitophagy, inflammation, and immune signaling mean that caution is reasonable alongside immunosuppressants, anticoagulants, and drugs with a narrow therapeutic window. Consult a pharmacist or clinician if you take prescription medications regularly.
Dosing safety: The most commonly used and studied dose is 500 mg to 1,000 mg daily. Going beyond 1,000 mg per day moves into territory with less safety data. There is no established tolerable upper limit from regulatory agencies at this point.
FDA’s GRN 791 letter for urolithin A says it has no questions about food uses at up to 500 mg per serving in shakes, bars and yogurt drinks (up to 1,000 mg in yogurts), states that it is not an affirmation of GRAS status, and did not evaluate any labeling or health claims. It does not describe a capsule or softgel use. Separately, one review argued that urolithins should be further evaluated for high-dose toxicity [8][9].
Quality and contamination concerns: Because urolithin A is sold as a dietary supplement in many countries, quality varies meaningfully between manufacturers. Third-party testing and certificate of analysis documentation matter here. Branded ingredients with published clinical data, like Mitopure, carry more transparency than generic bulk powders, though they come at a significantly higher price. Budget options sourced from less-established suppliers carry an unknown contamination and purity risk.
Community Insights
Limited DataAggregated from 6 self-reported experiences collected from public Reddit discussions. Not medical advice.
This reflects self-reported user experiences from public forums, not clinical data. Individual results vary. Consult a healthcare professional.
What real users report
Synthesizing discussions across r/Supplements, r/Menopause, r/floxies, r/methylene_blue, and other communities, a few clear themes emerge. These are real user experiences, not clinical findings, and they vary considerably.
Research note: The notifier states, based on published studies, that urolithin A is neither mutagenic nor genotoxic; this is the notifier’s statement as relayed in FDA’s letter [8].
Theme 1: Muscle strength and energy are the most commonly reported benefits
Across communities, the most consistent positive reports center on muscle-related outcomes. One r/Supplements user stated they could “tell the difference in my strength, muscle retention and skin.” Energy and endurance come up frequently as well. A user in r/methylene_blue noted “definitely getting an energy boost” after just a few days on a bulk urolithin A source, though they were appropriately cautious about whether it would last. Many users frame their experience as subtle rather than dramatic, more of a gradual baseline improvement than an acute noticeable effect.
Theme 2: Many people genuinely cannot tell if it is working
A recurring and honest theme is uncertainty. The user who tried Mitopure for roughly a year wrote that they “didn’t really feel that different while taking it.” Multiple users in r/Menopause and r/Supplements place urolithin A in a large stack of supplements, making it nearly impossible to isolate its contribution. One user summarized this honestly: “Hard for me to say which one is helping.” This is not a red flag for safety, but it is worth acknowledging that subjective benefit is far from universal.
Theme 3: Users in specific health contexts report cautious optimism
In r/floxies, a community for people recovering from fluoroquinolone antibiotic damage, one user documented a thoughtful comparison between Mitopure (urolithin A) and NMN for mitochondrial recovery. They found some subjective benefit in the context of muscle pain and exercise intolerance, and framed their reasoning around the mitophagy mechanism. Separately, a post in r/melahomies described a caregiver adding urolithin A to a broader supplement protocol for a spouse undergoing immunotherapy for stage 4 melanoma, while explicitly noting this was personal experience only and urging others to consult their physician. These reports are not safety warnings, but they underscore how urolithin A is being used in medically complex situations where more caution, not less, is warranted.
Theme 4: Cost and sourcing generate real frustration
Across multiple communities, the price of established branded urolithin A products is a consistent complaint. This has pushed some users toward cheaper bulk suppliers, a tradeoff that several people discuss openly. The r/NMN thread about Nestle threatening legal action against DoNotAge over their urolithin A product illustrates that the commercial and legal landscape around this ingredient is genuinely complicated, with intellectual property disputes affecting which products are available and at what price. Users sourcing from lesser-known suppliers should be aware that purity and dosing accuracy are not guaranteed.
Theme 5: Stacking urolithin A with many other supplements is common
A striking pattern in these communities is that very few people take urolithin A alone. The supplement stacks described include creatine, NMN, NR, magnesium, collagen, berberine, CoQ10, spermidine, and many others. This makes attributing any side effect, or any benefit, genuinely difficult. It also means that reported side effects in these communities may not be from urolithin A specifically.
Who should be cautious
- Pregnant or breastfeeding women (no safety trials exist) [6]
- Anyone in active cancer treatment, particularly immunotherapy or chemotherapy
- People taking immunosuppressant medications
- People on anticoagulants or drugs with narrow therapeutic windows
- Anyone with significant liver or kidney disease, given the limited data in these populations
- People sourcing from unverified bulk suppliers without third-party testing
- Anyone considering doses above 1,000 mg daily without medical supervision
If you fall into any of these categories, speak with a clinician before starting urolithin A. This article is informational and does not constitute medical advice.
FAQ
Is urolithin A safe for long-term use?
The honest answer is that we do not yet know with certainty. Trials to date have run for months, not years. The short-to-medium-term profile looks favorable in healthy adults, but multi-year safety data does not exist. This is not unique to urolithin A; it is true of most newer supplement ingredients. If you choose to use it long term, periodic check-ins with a clinician are a reasonable precaution.
Can urolithin A cause digestive problems?
Mild gastrointestinal symptoms, particularly loose stools and nausea, are the most commonly reported side effects in both clinical trials and user communities. The trials do not show a clear dose pattern for adverse events, and the 500 mg group reported fewer events than placebo in the middle-aged trial [4]. Starting at a lower dose and taking it with food may reduce this risk.
Is urolithin A safe to take with NMN or NR?
No known interaction between urolithin A and NMN or NR has been identified in the literature. Many users in communities like r/NicotinamideRiboside combine these without reporting problems. However, combining multiple mitochondria-targeted supplements is understudied, and the cumulative effect of doing so long term is not established.
Is the supplement form as safe as getting urolithin A from food?
Urolithin A produced naturally in the gut from foods like pomegranates, walnuts, and berries is considered safe, though many people produce little or none: in a trial of 100 healthy US adults, 33% could not convert pomegranate juice to urolithin A and 27% converted poorly while the rest were high converters [7]. Supplement forms deliver much higher concentrations than food typically would. This is not necessarily a safety concern based on current evidence, but it is a meaningful difference worth noting, particularly when going above standard doses.
The user-experience section reflects themes synthesized from public discussions on Reddit communities (r/NMN, r/AdvancedFitness, r/floxies). Individual experiences vary and are not medical advice. Consult a healthcare professional before starting or stopping any supplement.
References
- Andreux PA et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature metabolism (2019). PMID 32694802
- Kuerec AH et al. Targeting aging with urolithin A in humans: A systematic review. Ageing research reviews (2024). PMID 39002645
- Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA network open (2022). PMID 35050355
- Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell reports. Medicine (2022). PMID 35584623
- Denk D et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature aging (2025). PMID 41174221
- Henning SM et al. Pomegranate juice alters the microbiota in breast milk and infant stool: a pilot study. Food & function (2022). PMID 35510588
- Singh A et al. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population. European journal of clinical nutrition (2022). PMID 34117375
- U.S. Food and Drug Administration Agency Response Letter GRAS Notice No. GRN 000791. U.S. Food and Drug Administration (2018). source
- Aichinger G Natural Dibenzo-α-Pyrones: Friends or Foes?. International journal of molecular sciences (2021). PMID 34884865
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.